Multi-institutional feasibility and safety outcomes of retroperitoneal robot-assisted partial nephrectomy in morbidly obese patients
Thomas E. Stout(University of Iowa), Paul T. Gellhaus(University of Iowa), Hiten D. Patel(Northwestern University), Gopal N. Gupta(Loyola University Medical Center), Aaron Smith(University of California, Berkeley), Ian M. McElree(Vanderbilt University Medical Center), Goran Rac(Loyola University Medical Center)
Cited by 2
Related Papers
Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes
|Oncogenesis|2015|185
Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer
|JAMA Network Open|2023|116
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer
|The Journal of Urology|2022|71
Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer
|Urologic Oncology Seminars and Original Investigations|2022|59